Assets

The company's long-term assets, including property, plant, and equipment, as well as goodwill, appear to be well-maintained, with a slight decrease in value over the past year, suggesting a cautious approach to capital expenditures. The short-term assets, such as cash and cash equivalents, have shown a significant increase, indicating a strong liquidity position, but the company's reliance on short-term financing may pose a risk to its long-term financial stability. Overall, the company's total assets and investments appear to be well-balanced, with a moderate level of debt and a significant amount of equity, suggesting a prudent approach to financial management.

Shareholders Equity

The company's Shareholders Equity has shown a decline in the current period, primarily due to a decrease in retained earnings, which suggests that the company has been experiencing a reduction in profitability. This decline in profitability can be attributed to the company's inability to manage its operating expenses effectively, as evident from the increase in employee benefit expenses and other operating expenses. Furthermore, the company's failure to generate sufficient revenue growth, particularly in the Healthcare Services segment, has also contributed to the decline in Shareholders Equity.

The value of Pihlajalinna Equity at the end of Q2 2026 is 165.5 million Euros. The predicted value of Pihlajalinna Equity at the end of Q2 2027 (e) is 174.2 million Euros. The expected change in one year from Q2 2026 to Q2 2027 (e) is 8.7 million Euros, which is a 5.3% increase. The equity value is expected to decrease by 20.2 million Euros from 2025 to 2026, which is a 10.6% decrease. From 2026 to 2027, the equity value is expected to increase by 7.2 million Euros, which is a 4.2% increase. The year-end values for Equity are 190.6 million Euros in 2025, 170.4 million Euros in 2026, and 178.6 million Euros in 2027.

*Future dividents are not included in prediction

Debt

Pihlajalinna's long-term debt structure appears to be well-managed, with a recent extension of its financing arrangement to June 2029, providing a stable outlook for the company's capital commitments. However, the high gearing ratio, driven by a significant amount of interest-bearing financial liabilities, may pose a risk to the company's financial flexibility and ability to absorb potential shocks. Nevertheless, the company's equity ratio remains relatively healthy, indicating a strong foundation for long-term growth and resilience in the face of market fluctuations.

The Net Debt in Q2 2026 is 289.3 million Euros. The predicted Net Debt in Q2 2027 (e) is 241.0 million Euros. The expected change in Net Debt from Q2 2026 to Q2 2027 (e) is a decrease of 48.3 million Euros. This represents a decrease of approximately 16.7% from the Q2 2026 Net Debt value. The Net Debt is expected to increase by 1.8 million Euros from 2025 to 2026, which is a 0.66% change. From 2026 to 2027, the Net Debt is expected to decrease by 38.3 million Euros, representing a 14.0% change. The year-end Net Debt values for the respective years are 271.7 million Euros in 2025, 272.5 million Euros in 2026, and 234.2 million Euros in 2027.